These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27650681)

  • 21. Exenatide.
    Bray GM
    Am J Health Syst Pharm; 2006 Mar; 63(5):411-8. PubMed ID: 16484515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
    Parkes DG; Mace KF; Trautmann ME
    Expert Opin Drug Discov; 2013 Feb; 8(2):219-44. PubMed ID: 23231438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials.
    Klünder B; Mittapalli RK; Mohamed MF; Friedel A; Noertersheuser P; Othman AA
    Clin Pharmacokinet; 2019 Aug; 58(8):1045-1058. PubMed ID: 30945116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study.
    Malloy J; Capparelli E; Gottschalk M; Guan X; Kothare P; Fineman M
    Clin Ther; 2009 Apr; 31(4):806-15. PubMed ID: 19446153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exenatide.
    Barnett AH
    Drugs Today (Barc); 2005 Sep; 41(9):563-78. PubMed ID: 16341288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
    Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
    Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV Infusion.
    Cirincione B; LaCreta F; Sager P; Mager DE
    J Clin Pharmacol; 2017 Aug; 57(8):956-965. PubMed ID: 28543393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.
    Magnusson MO; Samtani MN; Plan EL; Jonsson EN; Rossenu S; Vermeulen A; Russu A
    Clin Pharmacokinet; 2017 Apr; 56(4):421-433. PubMed ID: 27743205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials.
    Geiser JS; Heathman MA; Cui X; Martin J; Loghin C; Chien JY; de la Peña A
    Clin Pharmacokinet; 2016 May; 55(5):625-34. PubMed ID: 26507721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptin.
    Naik H; Czerniak R; Vakilynejad M
    Br J Clin Pharmacol; 2016 Apr; 81(4):700-12. PubMed ID: 26617339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes.
    Molina Vega M; Muñoz-Garach A; Tinahones FJ
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):207-217. PubMed ID: 29260924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide-loaded PLGA microspheres with improved glycemic control: in vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats.
    Xuan J; Lin Y; Huang J; Yuan F; Li X; Lu Y; Zhang H; Liu J; Sun Z; Zou H; Chen Y; Gao J; Zhong Y
    Peptides; 2013 Aug; 46():172-9. PubMed ID: 23770254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exenatide: a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea).
    Cvetković RS; Plosker GL
    Drugs; 2007; 67(6):935-54. PubMed ID: 17428109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes.
    Taylor K; Kim D; Nielsen LL; Aisporna M; Baron AD; Fineman MS
    Horm Metab Res; 2005 Oct; 37(10):627-32. PubMed ID: 16278786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of gliclazide in normal and diabetic rabbits.
    Shaik M; Shaik S; Kilari EK
    Biopharm Drug Dispos; 2018 May; 39(5):265-274. PubMed ID: 29679474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.
    Chen C; Zheng H; Xu J; Shi X; Li F; Wang X
    Daru; 2017 Sep; 25(1):20. PubMed ID: 28870261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exenatide: a new option for the treatment of type 2 diabetes.
    Yoo BK; Triller DM; Yoo DJ
    Ann Pharmacother; 2006 Oct; 40(10):1777-84. PubMed ID: 16985091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.